Clinicopathological characteristics and treatment of breast myofibroblastoma

Yang WANG,Xiang WANG,Xin WANG,Wen-yan WANG,Ping ZHAO
DOI: https://doi.org/10.11877/j.issn.1672-1535.2015.13.03.14
2015-01-01
Abstract:Objective To investigate the clinicopathological characteristics and treatment of breast myofibroblasto-ma (MFB). Method The clinical and pathological profile of breast myofibroblastoma of 3 patients was reviewed, to analyze the clinicopathological characteristics and therapy of this rare tumor. Result All the 3 patients were pre-menopausal women. MFB is presented by both palpation and imaging examination as < 2 cm, solitary, unilateral, painless, freely movable nodule in all patients, who were administered with tumor resection, and the paraffin embed-ding samples were confirmed pathologically as myofibroblastoma. In immunohistochemistry, the expression of SMA, vimentin and desmin were positive, whereas the expression of S-100 was negtive. No postoperative adjuvant treat-ment was performed. All 3 patients were well restored and followed up by Oct, 2014, and neither recurrence nor me-tastasis was observed. Conclusion Myofibroblastoma of the breast is a rare benign stromal tumor in premenopausal women with a good prognosis. Tumor resection is the applicable treatment. The diagnosis must be based on pathologi-cal characteristics, and immunohistochemical markers (SMA, vimentin, desmin and S-100) may be useful in the diag-nosis.
What problem does this paper attempt to address?